Friday, January 23, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Conagra Brands Faces Mounting Pressure as Goldman Sachs Issues Sell Warning

Andreas Sommer by Andreas Sommer
November 27, 2025
in Analysis, Consumer & Luxury, Dividends
0
Conagra Brands Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

The packaged food sector is experiencing significant headwinds, with Conagra Brands emerging as one of the most vulnerable players. As the company’s shares continue their downward trajectory, Goldman Sachs has intensified its pessimistic stance, forecasting further declines despite the stock’s attractive dividend yield.

Deepening Analyst Pessimism

In a pre-Thanksgiving analysis that sent ripples through the market, Goldman Sachs slashed its price target for Conagra Brands to just $16 per share—the most bearish projection among all covering analysts. This revised target suggests potential additional downside of nearly 10% for shares that have already plummeted over 36% year-to-date.

Analyst Leah Jordan reaffirmed her “Sell” rating, citing heightened concerns about the company’s capacity to drive growth amid persistent inflationary pressures. While most Wall Street analysts maintain “Hold” positions, Goldman Sachs has positioned itself as the clearest bearish voice on the stock.

Dividend Appeal Masks Fundamental Weakness

Investors face a challenging conundrum: the stock offers a historically high dividend yield approaching 8%, yet underlying business metrics show clear deterioration. The most recent quarterly results revealed a concerning 5.8% revenue decline, despite earnings figures that surpassed expectations.

The core issue remains shrinking volume as consumers increasingly shift to more affordable private-label alternatives, resisting Conagra’s price increases implemented over the past two years. While the substantial dividend initially appears appealing, capital depreciation throughout this year has resulted in negative total returns for shareholders.

Should investors sell immediately? Or is it worth buying Conagra Brands?

Sector-Wide Challenges Hit Conagra Disproportionately

The pressures confronting Conagra reflect broader challenges within the packaged food industry, though the company appears to be suffering more severely than its competitors. While the S&P 500 has delivered double-digit gains in 2025, this traditionally defensive stock has significantly underperformed.

Historically, Conagra leveraged its brand strength to pass cost increases along to consumers. Current performance indicators, however, suggest this strategy may have reached its limit. The company’s five-year average return on capital of just 5.3% further signals operational efficiency concerns.

Critical Support Level in Focus

Conagra maintains its earnings guidance for fiscal 2026, though market participants remain skeptical as shares hover near annual lows. Technical analysts are closely monitoring the $16 level as a crucial support zone.

A breach of this threshold could trigger additional selling pressure, particularly from dividend-focused funds that may no longer justify holding the position based on payout income alone. The upcoming quarterly report represents a critical test, with investors seeking concrete evidence that the company can stem its volume declines.

Ad

Conagra Brands Stock: Buy or Sell?! New Conagra Brands Analysis from January 23 delivers the answer:

The latest Conagra Brands figures speak for themselves: Urgent action needed for Conagra Brands investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 23.

Conagra Brands: Buy or sell? Read more here...

Tags: Conagra Brands
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Arcutis Biotherapeutics Stock
Analysis

Arcutis Biotherapeutics Schedules Fourth Quarter and Full-Year 2025 Earnings Release

January 23, 2026
Fiserv Stock
Analysis

Fiserv’s Strategic Crossroads: Balancing Expansion with Investor Confidence

January 23, 2026
Coinbase Stock
Analysis

Political Headwinds Challenge Coinbase’s Regulatory Strategy

January 23, 2026
Next Post
TSMC Stock

TSMC's Strategic Offensive: A Dual-Pronged Assault on the Semiconductor Sector

Amazon Stock

Amazon's High-Stakes Holiday: AI Ambitions Clash with Operational Headwinds

Super Micro Computer Stock

Super Micro Computer Stock: A Critical Juncture

Recommended

Babcock & Wilcox Enterprises Stock

Market Skepticism Sinks Babcock & Wilcox Shares Despite Major Contract

4 months ago
Salesforce Stock

Salesforce Bets Big on AI with Major San Francisco Investment

3 months ago
Microsoft Stock

Microsoft Charts Independent AI Course with New In-House Models

5 months ago
Intel Stock

Nvidia’s Strategic Investment in Intel Sends Shockwaves Through Semiconductor Sector

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Political Headwinds Challenge Coinbase’s Regulatory Strategy

Take-Two Shares Navigate a Holding Pattern Ahead of Grand Theft Auto VI Launch

Cardano Approaches a Technical and Fundamental Inflection Point

Salesforce at a Crossroads: AI Ambition Meets Market Anxiety

Oracle’s Strategic Gambit: A High-Stakes Clash Between TikTok Deal and Bearish Bets

The iShares MSCI World ETF’s Growing Reliance on Technology Giants

Trending

BYD Stock
Asian Markets

BYD’s Global Expansion Strategy Gains Momentum

by Dieter Jaworski
January 23, 2026
0

The strategic initiatives undertaken by Chinese electric vehicle (EV) giant BYD are yielding tangible results across multiple...

Arcutis Biotherapeutics Stock

Arcutis Biotherapeutics Schedules Fourth Quarter and Full-Year 2025 Earnings Release

January 23, 2026
Fiserv Stock

Fiserv’s Strategic Crossroads: Balancing Expansion with Investor Confidence

January 23, 2026
Coinbase Stock

Political Headwinds Challenge Coinbase’s Regulatory Strategy

January 23, 2026
Take-Two Stock

Take-Two Shares Navigate a Holding Pattern Ahead of Grand Theft Auto VI Launch

January 23, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BYD’s Global Expansion Strategy Gains Momentum
  • Arcutis Biotherapeutics Schedules Fourth Quarter and Full-Year 2025 Earnings Release
  • Fiserv’s Strategic Crossroads: Balancing Expansion with Investor Confidence

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com